Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
3.890
+0.100 (2.64%)
At close: Jul 20, 2026, 4:00 PM EDT
3.937
+0.047 (1.21%)
Pre-market: Jul 21, 2026, 4:43 AM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.1 million as of July 20, 2026. Its market cap has decreased by -25.67% in one year.
Market Cap
3.10M
Enterprise Value
-3.00M
1-Year Change
-25.67%
Ranking
Category
Stock Price
$3.89
ChartMarket Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.10M, a decrease of -98.50%. That is a compound annual growth rate of -65.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 3.10M | 20.77% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.38% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 3.90M |
| Onconetix | 3.69M |
| Genprex | 3.47M |
| GeoVax Labs | 3.42M |
| Galmed Pharmaceuticals | 3.40M |
| Creative Medical Technology Holdings | 3.19M |
| Propanc Biopharma | 3.14M |
| Decoy Therapeutics | 2.82M |